Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing deal worth up to $1.3 billion. | Novo Nordisk alleges Singaporean biotech KBP ...
Lawsuits surrounding Merck's HPV vaccine Gardasil have been piling up for years now, but they've garnered increased public ...
Following similar deals in countries like the United States and the U.K., Canada is bolstering its stockpile of bird flu ...
A popular awareness campaign now in its second year that encouraged people to get flu vaccines to reduce their risk of severe ...
Less than a week after newly confirmed Department of Health and Human Services (HHS) secretary Robert F. Kennedy Jr. | Less than a week after newly confirmed HHS secretary Robert F. Kennedy Jr.
As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...
From turning away inspectors to falsifying data and leaving "bare footprints" in production containers, two of the latest ...
Challenging powerhouse Pfizer, BridgeBio's launch of Attruby is off to a 'great start,' analyst says
An intriguing battle is brewing in the market to treat patients with transthyretin amyloid cardiomyopathy (ATTR-CM). | BridgeBio reported that 1,028 unique prescriptions have been written by 516 ...
AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to ...
Merck KGaA’s U.S. pharma arm has recruited actor Selma Blair for a collaboration around multiple sclerosis treatment Mavenclad. | No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited ...
Genentech and Novartis have teamed up with Food Allergy Research & Education (FARE) to enhance the safety of children with ...
The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback